Trials / Completed
CompletedNCT04242394
If Chronic Gallbladder Diseases Increase the Incidence of PEC
If Chronic Gallbladder Diseases Increase the Occurence of Post Endoscopic Retrograde Choledochopancreatography Choledocholithiasis(a Prospective Multi-center Cohort Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,019 (actual)
- Sponsor
- Hepatopancreatobiliary Surgery Institute of Gansu Province · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, multi-centre trial conducts at 4 ERCP centers in China designed to determine if chronic gallbladder diseases increase the incidence of Post-Endoscopic Retrograde Choledochopancreatography-Choledocholithiasis (PEC)
Detailed description
Endoscopic Retrograde Choledochopancreatography(ERCP) has the advantages of less injury and faster recovery for common bile duct stone patients. However, according to our retrospective study, ERCP will has a mostly 10% possibility to get an acute purulent cholecystitis which often requires emergency intervention, when patients combined with chronic gallbladder diseases, such as chronic cholecystitis, asymptomatic gallstones, and gallbladder wall thickness, the incidence of PEC will increase accordingly. The aim of this study is to observe if chronic gallbladder disease will increase the occurence of PEC and develop a high-risk PEC model.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ERCP | Routine ERCP procedures with gallbladder in situ patient |
Timeline
- Start date
- 2020-02-14
- Primary completion
- 2024-11-16
- Completion
- 2024-11-16
- First posted
- 2020-01-27
- Last updated
- 2025-12-19
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04242394. Inclusion in this directory is not an endorsement.